ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. [PDF]
Salami F +18 more
europepmc +1 more source
Population Pharmacokinetic Modeling and Pediatric Exposure of Dexamethasone Sodium Phosphate Encapsulated in Erythrocytes (eDSP) Administered Monthly for Treatment of Neurological Symptoms of Patients With Ataxia Telangiectasia. [PDF]
Ozdin D +4 more
europepmc +1 more source
PARP inhibitor BMN673 triggers PARylation-mediated ATF4-GDF15 pathway to drive autophagy and ferroptosis in ataxia telangiectasia mutated gene-deficient colorectal cancer cells. [PDF]
Xiang J +11 more
europepmc +1 more source
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis. [PDF]
Lynch M +27 more
europepmc +1 more source
Primary Immunodeficiency-Type Ataxia-Telangiectasia Revealed by Splenic Abscesses. [PDF]
Bebana A +5 more
europepmc +1 more source
Disruption of ataxia telangiectasia-mutated kinase enhances radiation therapy efficacy in spatially directed diffuse midline glioma models. [PDF]
Mangoli A +28 more
europepmc +1 more source
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia. [PDF]
Koenig MK +21 more
europepmc +1 more source
Correction: Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. [PDF]
europepmc +1 more source

